Transient elastography in patients with celiac disease: A noninvasive method to detect liver involvement associated with celiac disease

References

• Tack GJ, Verbeek WH, Schreurs MW, Mulder CJ. The spectrum of celiac disease: epidemiology, clinical aspects and treatment. Nat Rev Gastroenterol Hepatol 2010;7:204–13.
   PubMed Web of Science ®Google Scholar
• Mirzaagha F, Azali SH, Islami F, Zamani F, Khalilipour E, Khatibian M, Coeliac disease in autoimmune liver disease: a cross-sectional study and a systematic review. Dig Liver Dis 2010;42:620–3.
   PubMedGoogle Scholar
• Rubio-Tapia A, Murray JA. Celiac disease. Curr Opin Gastroenterol 2010;26:116–22.
   PubMed Web of Science ®Google Scholar
• Schuppan D, Junker Y, Barisani D. Celiac disease: from pathogenesis to novel therapies. Gastroenterology 2009;137:1912–33.
   PubMed Web of Science ®Google Scholar
• Di Sabatino A, Corazza GR. Coeliac disease. Lancet 2009;373:1480–93.
   PubMed Web of Science ®Google Scholar
• Kagnoff MF. Celiac disease: pathogenesis of a model immunogenetic disease. J Clin Invest 2007;117:41–9.
   PubMed Web of Science ®Google Scholar
• Rostom A, Murray JA, Kagnoff MF. American gastroenterological association (aga) institute technical review on the diagnosis and management of celiac disease. Gastroenterology 2006;131:1981–2002.
   PubMed Web of Science ®Google Scholar
• Hernandez L, Green PH. Extraintestinal manifestations of celiac disease. Curr Gastroenterol Rep 2006;8:383–9.
   PubMedGoogle Scholar
• Schuppan D, Ciccocioppo R. Coeliac disease and secondary autoimmunity. Dig Liver Dis 2002;34:13–15.
   PubMedGoogle Scholar
• Rubio-Tapia A, Murray JA. The liver in celiac disease. Hepatology 2007;46:1650–8.
   PubMed Web of Science ®Google Scholar
• Kinney MO. Mildly abnormal liver tests. Don't forget coeliac disease and drug history. BMJ 2010;341:c4603.
   Google Scholar
• Volta U. Pathogenesis and clinical significance of liver injury in celiac disease. Clinic Rev Allerg Immunol 2009;36:62–70.
   PubMed Web of Science ®Google Scholar
• Duggan JM, Duggan AE. Systematic review: the liver in celiac disease. Aliment Pharmacol Ther 2005;21:515–18.
   PubMed Web of Science ®Google Scholar
• Pollock DJ. The liver in celiac disease. Histopathology 1977;1:421–30.
   PubMed Web of Science ®Google Scholar
• Maggiore G, Caprai S. The liver in celiac disease. J Pediatr Gastroenterol Nutr 2003;37:117–19.
   PubMed Web of Science ®Google Scholar
• Bardella MT, Vecchi M, Conte D, Del Ninno E, Fraquelli M, Pacchetti S, Chronic unexplained hypertransaminasemia may be caused by occult celiac disease. Hepatology 1999;29:654–7.
   PubMed Web of Science ®Google Scholar
• Volta U, De Franceschi L, Lari F, Molinaro N, Zoli M, Bianchi FB. Coeliac disease hidden by cryptogenic hypertransaminasaemia. Lancet 1998;352:26–9.
   PubMed Web of Science ®Google Scholar
• Lindgren S, Sjöberg K, Eriksson S. Unsuspected coeliac disease in chronic 'cryptogenic' liver disease. Scand J Gastroenterol 1994;29:661–4.
   PubMed Web of Science ®Google Scholar
• Bardella MT, Fraquelli M, Quatrini M, Molteni N, Bianchi P, Conte D. Prevalence of hypertransaminasemia in adult coeliac patients and effect of gluten-free diet. Hepatology 1995;22:833–6.
   PubMed Web of Science ®Google Scholar
• Logan RF, Ferguson A, Finlayson ND, Weir DG. Primary biliary cirrhosis and celiac disease: an association? Lancet 1978;1:230–3.
   PubMed Web of Science ®Google Scholar
• Sorensen HT, Thulstrup AM, Blomqvist P, Nørgaard B, Fonager K, Ekbom A. Risk of primary biliary liver cirrhosis in patients with coeliac disease: Danish and Swedish cohort data. Gut 1999;44:736–8.
   PubMed Web of Science ®Google Scholar
• Feld JJ, Meddings J, Heathcote EJ. Abnormal intestinal permeability in primary biliary cirrhosis. Dig Dis Sci 2006;51:1607–13.
   PubMed Web of Science ®Google Scholar
• Watt FE, James OF, Jones DE. Patterns of autoimmunity in primary biliary cirrhosis patients and their families: a population-based cohort study. QJM 2004;97:397–406.
   PubMed Web of Science ®Google Scholar
• Ludvigsson JF, Elfström P, Broomé U, Ekbom A, Montgomery SM. Celiac disease and risk of liver disease: a general population-based study. Clin Gastroenterol Hepatol 2007;5:63–9.
   PubMed Web of Science ®Google Scholar
• Volta U, De Franceschi L, Molinaro N, Cassani F, Muratori L, Lenzi M, Frequency and significance of anti-gliadin and anti-endomysial antibodies in autoimmune hepatitis. Dig Dis Sci 1998;43:2190–5.
   PubMed Web of Science ®Google Scholar
• Teufel A, Weinmann A, Kahaly GJ, Centner C, Piendl A, Wörns M, Concurrent autoimmune diseases in patients with autoimmune hepatitis. J Clin Gastroenterol 2010;44:208–13.
   PubMed Web of Science ®Google Scholar
• Kaukinen K, Halme L, Collin P, Färkkilä M, Mäki M, Vehmanen P, Celiac disease in patients with severe liver disease: gluten-free diet may reverse hepatic failure. Gastroenterology 2002;122:881–8.
   PubMed Web of Science ®Google Scholar
• Bardella MT, Elli L, De Matteis S, Floriani I, Torri V, Piodi L. Autoimmune disorders in patients affected by celiac sprue and inflammatory bowel disease. Ann Med 2009;41:139–43.
   PubMed Web of Science ®Google Scholar
• Rubio-Tapia A, Abdulkarim AS, Wiesner RH, Moore SB, Krause PK, Murray JA. Celiac disease autoantibodies in severe autoimmune liver disease and the effect of liver transplantation. Liver Int 2008;28:467–76.
   PubMed Web of Science ®Google Scholar
• Freeman HJ. Hepatobiliary and pancreatic disorders in celiac disease. World J Gastroenterol 2006;12:1503–8.
   PubMed Web of Science ®Google Scholar
• Lindberg T, Berg NO, Borulf S, Jakobsson I. Liver damage in coeliac disease or other food intolerance in childhood. Lancet 1978;1:390–1.
   PubMed Web of Science ®Google Scholar
• Novacek G, Miehsler W, Wrba F, Ferenci P, Penner E, Vogelsang H. Prevalence and clinical importance of hypertransaminasaemia in coeliac disease. Eur J Gastroenterol Hepatol 1999;11:283–8.
   PubMed Web of Science ®Google Scholar
• Stevens FM, McLoughlin RM. Is coeliac disease a potentially treatable cause of liver failure? Eur J Gastroenterol Hepatol 2005;17:1015–17.
   PubMed Web of Science ®Google Scholar
• Ventura A, Magazzù G, Greco L. Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease. SIGEP study group for autoimmune disorders in celiac disease. Gastroenterology 1999;117:297–303.
   PubMed Web of Science ®Google Scholar
• Korponay-Szabó IR, Halttunen T, Szalai Z, Laurila K, Király R, Kovács JB, In vivo targeting of intestinal and extraintestinal transglutaminase 2 by coeliac autoantibodies. Gut 2004;53:641–8.
   PubMed Web of Science ®Google Scholar
• Smyth C, Kelleher D, Keeling PW. Hepatic manifestations of gastrointestinal diseases. inflammatory bowel disease, celiac disease, and Whipple's disease. Clin Liver Dis 2002;6:1013–32.
   PubMedGoogle Scholar
• Cassinotti A, Birindelli S, Clerici M, Trabattoni D, Lazzaroni M, Ardizzone S, HLA and autoimmune digestive disease: a clinically oriented review for gastroenterologists. Am J Gastroenterol 2009;104:195–217.
   PubMed Web of Science ®Google Scholar
• Boberg KM, Spurkland A, Rocca G, Egeland T, Saarinen S, Mitchell S, The HLA-DR3,DQ2 heterozygous genotype is associated with an accelerated progression of primary sclerosing cholangitis. Scand J Gastroenterol 2001;8:886–90.
   Google Scholar
• Castera L, Pinzani M. Biopsy and non-invasive methods for the diagnosis of liver fibrosis: does it take two to tango? Gut 2010;59:861–6.
   PubMed Web of Science ®Google Scholar
• Bedossa P, Carrat F. Liver biopsy: the best, not the gold standard. Journal of Hepatology 2009;50:1–3.
   PubMed Web of Science ®Google Scholar
• Rockey DC, Caldwell SH, Goodman ZD, Nelson RC, Smith AD. American association for the study of liver diseases. Liver Biopsy Hepatology 2009;49:1017–44.
   PubMed Web of Science ®Google Scholar
• Regev A, Berho M, Jeffers LJ, Milikowski C, Molina EG, Pyrsopoulos NT, Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 2002;97:2614–18.
   PubMed Web of Science ®Google Scholar
• Ziol M, Handra-Luca A, Kettaneh A, Christidis C, Mal F, Kazemi F, Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 2005;41:48–54.
   PubMed Web of Science ®Google Scholar
• Stebbing J, Farouk L, Panos G, Anderson M, Jiao LR, Mandalia S, A meta-analysis of transient elastography for the detection of hepatic fibrosis. J Clin Gastroenterol 2010;44:214–19.
   PubMed Web of Science ®Google Scholar
• Sandrin L, Fourquet B, Hasquenoph JM, Yon S, Fournier C, Mal F, Transient elastography: a new non-invasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 2003;29:1705–13.
   PubMed Web of Science ®Google Scholar
• Lewis NR, Scott BB. Systematic review: the use of serology to exclude or diagnose coeliac disease (a comparison of the endomysial and tissue transglutaminase antibody tests). Aliment Pharmacol Ther 2006;24:47–54.
   PubMed Web of Science ®Google Scholar
• Hill ID. What are the sensitivity and specificity of serologic tests for celiac disease? do sensitivity and specificity vary in different populations? Gastroenterology 2005;128(Suppl 1):S25–32.
   PubMedGoogle Scholar
• Marsh MN. Gluten, major histocompatibility complex, and the small intestine. a molecular and immunobiologic approach to the spectrum of gluten sensitivity ('celiac sprue'). Gastroenterology 1992;102:330–54.
   PubMed Web of Science ®Google Scholar
• Oberhuber G, Granditsch G, Vogelsang H. The histopathology of coeliac disease: time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol 1999;11:1185–94.
   PubMed Web of Science ®Google Scholar
• The French METAVIR Cooperative Study Group. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology 1994;20:15–20.
   PubMed Web of Science ®Google Scholar
• Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005;41:1313–21.
   PubMed Web of Science ®Google Scholar
• Castera L, Forns X, Alberti A. Non-invasive evaluation of liver fibrosis using transient elastography. J Hepatol 2008;48:835–47.
   PubMed Web of Science ®Google Scholar
• Del Poggio P, Colombo S. Is transient elastography a useful tool for screening liver disease? World J Gastroenterol 2009;15:1409–14.
   PubMed Web of Science ®Google Scholar
• Roulot D, Czernichow S, Le Clésiau H, Costes JL, Vergnaud AC, Beaugrand M. Liver stiffness values in apparently healthy subjects: influence of gender and metabolic syndrome. J Hepatol 2008;48:606–13.
   PubMed Web of Science ®Google Scholar
• Stasi C, Arena U, Vizzutti F, Zignego AL, Monti M, Laffi G, Transient elastography for the assessment of liver fibrosis in patients with chronic viral hepatitis: the missing tool? Dig Liver Dis 2009;41:863–6.
   PubMedGoogle Scholar
• Friedrich-Rust M, Ong MF, Martens S, Sarrazin C, Bojunga J, Zeuzem S, Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology 2008;134:960–74.
   PubMed Web of Science ®Google Scholar
• Fraquelli M, Rigamonti C, Casazza G, Conte D, Donato MF, Ronchi G, Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease. Gut 2007;56:968–73.
   PubMed Web of Science ®Google Scholar
• Castera L. Invasive and non-invasive methods for the assessment of fibrosis and disease progression in chronic liver disease. Best Pract Res Clin Gastroenterol 2011;25:291–303.
   PubMed Web of Science ®Google Scholar
• Corpechot C, El Naggar A, Poupon R. Gender and liver: is the liver stiffness weaker in weaker sex? Hepatology 2006;44:513–14.
   PubMed Web of Science ®Google Scholar
• Colombo S, Belloli L, Zaccanelli M, Badia E, Jamoletti C, Buonocore M, Normal liver stiffness and its determinants in healthy blood donors. Dig Liver Dis 2011;43:231–6.
   PubMedGoogle Scholar
• Elli L, Bergamini CM, Bardella MT, Schuppan D. Transglutaminases in inflammation and fibrosis of the gastrointestinal tract and the liver. Dig Liver Dis 2009;41:541–50.
   PubMedGoogle Scholar
• Nardacci R, Ciccosanti F, Falasca L, Lo Iacono O, Amendola A, Antonucci G, Tissue transglutaminase in HCV infection. Cell Death Differ 2003;10:S79–80.
   Web of Science ®Google Scholar
• Strnad P, Harada M, Siegel M, Terkeltaub RA, Graham RM, Khosla C, Transglutaminase 2 regulates Mallory body inclusion formation and injury-associated liver enlargement. Gastroenterology 2007;132:1515–26.
   PubMed Web of Science ®Google Scholar